$VNRX· SEC filing ·

VNRX Announces 1-for-20 Reverse Stock Split Approved by Shareholders, Effective April 28, 2026

VolitionRx Limited · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $2.65

-13% in 7d after detection

Post-detection moves

1h
1d
-5.0%
3d
-13%
7d
-13%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS